Auflistung nach Autor "Lauschke, Volker M."

Anzeige der Dokumente 1-20 von 26

Nächste Seite

3D microperfusion of mesoscale human microphysiological liver models improves functionality and recapitulates hepatic zonation

Lauschke, Volker M. (2023)
A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencing

Lauschke, Volker M. (2022)
An overlooked subset of Cx3cr1(wt/wt) microglia in the Cx3cr1(CreER-Eyfp/wt) mouse has a repopulation advantage over Cx3cr1(CreER-Eyfp/wt) microglia following microglial depletion

Lauschke, Volker M. (2022)
Bioengineered Pancreas-Liver Crosstalk in a Microfluidic Coculture Chip Identifies Human Metabolic Response Signatures in Prediabetic Hyperglycemia

Keulen, Jibbe; Klein, Kathrin; Büttner, Florian A.; Lauschke, Volker M. (2022)
Challenges and opportunities associated with rare-variant pharmacogenomics br

Tremmel, Roman; Schäffeler, Elke; Schwab, Matthias; Lauschke, Volker M. (2022)
CYP2C19 and CYP2D6 Genotypes and Metabolizer Status Distribution in a Bulgarian Psychiatric Cohort

Lauschke, Volker M. (2022)
Cyp3a4*22 and cyp3a5*3 impact efficacy and safety of diazepam in patients with alcohol withdrawal syndrome

Lauschke, Volker M. (2023)
Deep Annotation of Donated Chemical Probes (DCP) in Organotypic Human Liver Cultures and Patient-Derived Organoids from Tumor and Normal Colorectum

Lauschke, Volker M. (2023)
Enzymatically dissociated muscle fibers display rapid dedifferentiation and impaired mitochondrial calcium control

Lauschke, Volker M. (2022)
Genetic Testing is Superior Over Endogenous Pharmacometabolomic Markers to Predict Safety of Haloperidol in Patients with Alcohol-induced Psychotic Disorder

Lauschke, Volker M. (2022)
Genetic Variant ABCC1 rs45511401 Is Associated with Increased Response to Statins in Patients with Familial Hypercholesterolemia

Lauschke, Volker M. (2022)
Global distribution of functionally important CYP2C9 alleles and their inferred metabolic consequences

Lauschke, Volker M. (2023)
GLP-1R signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimetics

Lauschke, Volker M. (2023)
Human resident liver myeloid cells protect against metabolic stress in obesity

Lauschke, Volker M. (2023)
Identification and functional validation of novel pharmacogenomic variants using a next-generation sequencing-based approach for clinical pharmacogenomics

Lauschke, Volker M. (2022)
Identification of CCZ1 as an essential lysosomal trafficking regulator in Marburg and Ebola virus infections

Lauschke, Volker M. (2023)
In vitro and ex vivo modeling of enteric bacterial infections

Lauschke, Volker M. (2023)
Incorporating New Approach Methodologies into Regulatory Nonclinical Pharmaceutical Safety Assessment

Lauschke, Volker M. (2023)
Meta-analysis of pharmacogenetic clinical decision support systems for the treatment of major depressive disorder

Lauschke, Volker M. (2023)
Multi-Well Array Culture of Primary Human Hepatocyte Spheroids for Clearance Extrapolation of Slowly Metabolized Compounds

Lauschke, Volker M. (2022)

Anzeige der Dokumente 1-20 von 26

Nächste Seite

Veröffentlichen

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Einloggen

Auflistung nach Autor "Lauschke, Volker M."

Auflistung nach Autor "Lauschke, Volker M."

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Hilfe & Infos